Loading provider…
Loading provider…
Hematology & Oncology Physician in Indianapolis, IN
NPI: 1124102231Primary Practice Location
INDIANA UNIVERSITY HEALTH
1701 N Senate Blvd, Indianapolis, IN
Primary Employer
IU Health Medical Group, LLC
iuhealth.org
HQ Phone
Get MD Utpal's Phone NumberMobile
Get MD Utpal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 43 | 214 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 28 | 85 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 26 | 30 |
Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.
Authors: Roels, Juliette, Thénoz, Morgan, Szarzyńska, Bronisława, Landfors, Mattias, De Coninck, Stien, Demoen, Lisa, Provez, Lien, Kuchmiy, Anna, Strubbe, Steven, Reunes, Lindy, Pieters, Tim, Matthijssens, Filip, Van Loocke, Wouter, Erarslan-Uysal, Büşra, Richter-Pechańska, Paulina, Declerck, Ken, Lammens, Tim, De Moerloose, Barbara, Deforce, Dieter, Van Nieuwerburgh, Filip, Cheung, Laurence C, Kotecha, Rishi S, Mansour, Marc R, Ghesquière, Bart, Van Camp, Guy, Berghe, Wim Vanden, Kowalczyk, Jerzy R, Szczepański, Tomasz, Davé, Utpal P, Kulozik, Andreas E, Goossens, Steven, Curtis, David J, Taghon, Tom, Dawidowska, Małgorzata, Degerman, Sofie, Van Vlierberghe, Pieter
Journal: Blood Cancer Discov
Publication Date: 2020-09-23
A role for proapoptotic Bax and Bak in T-cell differentiation and transformation.
Authors: Biswas, Subhrajit, Shi, Qiong, Matise, Lauren, Cleveland, Susan, Dave, Utpal, Zinkel, Sandra
Journal: Blood
Publication Date: 2010-09-02
Lead Sponsor: Indiana University
Intervention / Treatment: BIOLOGICAL: COVID-19 Vaccination
Lead Sponsor: Ryan Wilcox
Collaborators: Takeda, University of Michigan Rogel Cancer Center
Intervention / Treatment: DRUG: Ixazomib, DRUG: Romidepsin